BIOMAT Database Logo BIOMAT Database Logo

[Comparison of the bioavailability of 2 different equal-dosage oral pharmaceutic forms of nimesulide in healthy volunteers]. 1986

A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca

UI MeSH Term Description Entries
D008297 Male Males
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
May 1989, Die Pharmazie,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Relative bioavailability of carbocysteine from three dosage forms, investigated in healthy volunteers.
January 1988, Biopharmaceutics & drug disposition,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
[Comparative bioavailability of 3 oral forms of metapramine in healthy volunteers].
January 1984, Therapie,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Bioavailability of valsartan oral dosage forms.
March 2014, Clinical pharmacology in drug development,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
A comparative bioavailability of 2 oral solid phenytoin dosage forms.
April 1989, The Central African journal of medicine,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Comparison of oral bioavailability of two dosage-forms of progesterone in women.
January 1991, European journal of drug metabolism and pharmacokinetics,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
[Intersubject comparison of the bioavailability of spironolactone in 2 pharmaceutical dosage forms].
August 1978, Bollettino chimico farmaceutico,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
October 1991, International journal of clinical pharmacology, therapy, and toxicology,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
The relative bioavailability of two marketed controlled release diltiazem dosage forms at steady state in healthy volunteers.
January 1996, Biopharmaceutics & drug disposition,
A Alessandrini, and E Ballarin, and A Bastianon, and C Migliavacca
Oral dosage forms and drug delivery systems: tablets, oral films, liquid dosage forms, oral bioavailability enhancement.
March 2017, Pharmaceutical development and technology,
Copied contents to your clipboard!